TRGP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TRGP is NOT a good buy right now. The trend is clearly bullish, but the stock is stretched/overbought (RSI-6 86.7) and trading near the first resistance zone (204). With no Intellectia buy signals today and near-term downside odds slightly outweighing upside in the pattern-based forecast, the risk/reward for an immediate entry at ~200 is unattractive. I would hold off on buying at current levels.
Trend: Bullish. Moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), confirming a strong uptrend. Momentum: MACD histogram is positive (1.719) but contracting, suggesting upside momentum is still positive yet cooling. Overbought: RSI_6 at ~86.7 is strongly overbought, which often precedes short-term pullbacks or consolidation. Key levels: Pivot ~193.56 (important near-term support/mean-reversion zone). Resistance R1 ~204.15 (near current price), then R2 ~210.69. With price ~200, upside to R1 is limited versus downside back toward the pivot. Quant/pattern read: Similar-pattern projection shows ~50% chance of -0.06% next day, -1.36% next week, -2.97% next month—tilting slightly negative near-term.
scheduled 2026-02-19 pre-market; could be a catalyst if guidance/volumes surprise higher.
Technical stretch: RSI is extremely overbought and MACD momentum is cooling; near-term pullback/consolidation risk is elevated.
Overhead resistance nearby: R1 ~204 is close, limiting immediate upside.
No supportive proprietary buy signal today (AI Stock Picker/SwingMax both absent).
News provided is not directly about TRGP; there is no clear, TRGP-specific positive headline catalyst in the summary.
Positioning risk: Extremely call-heavy options sentiment can become contrarian if expectations are crowded.
Latest reported quarter: 2025/Q3. Growth trends were strong:
Recent trend: Net-positive revisions. Multiple firms raised price targets into late 2025 and January 2026 (Morgan Stanley to $266; Scotiabank to $224; RBC to $218; Wells Fargo to $207), with most maintaining Overweight/Outperform/Buy-type ratings. Wall Street pros view (bull case): Best-in-class Permian positioning, scale/diversification, and accretive bolt-on acquisitions that can lift 2026 free cash flow; expectation of continued volume growth. Wall Street cons view (bear case): Some caution about macro softness into 2026 (noted by Goldman) and the stock’s run-up/valuation risk implied by near-term technical overextension. Influential/politician activity: No recent congress trading data available; hedge funds and insiders are reported as neutral with no significant recent trend.
